advance-nursing-practice-2018-scientifictracks

27 / 28

Advance Nursing Practice 2018
J u n e 2 1 - 2 2 , 2 0 1 8
P a r i s , F r a n c e
Page 55
Journal of Nursing and Health Studies
ISSN 2574-2825
6 t h I n t e r n a t i o n a l C o n f e r e n c e o n
Advance Nursing Practice
SincethedevelopmentofLeftVentricularAssistiveDevices(LVAD)technology
in the early 1960s, it has become an invaluable device for bridging patients
to heart transplant. Despitethe advancements in generations of LVADs, they
have not become a reliable alternative toheart transplant. This is due to the high
chances of lethal side effects that are having devastating consequences on
patient’s quality of life such as: blood coagulation (stroke),blood cell damage,
and gastrointestinal bleeding. The current generations of LVADs are axial and
centrifugal flow technology to provide continuous flow patterns for LVAD.
However, Corwave is revisiting the effects of the 1st generation of LVADs where
pulsatile flow was used. It is believed that pulsatile flow pumps reduced shear
stress and reduced over activation of baroreceptors in the aorta. The fault in
1st generation pulsatile pumps were their unreliability due to mechanical failure
but the concept of pulsatile and its effects on the heart may be crucial in LVAD
success in heart failure treatment It is a theory that long standing continuous
flow on the heart has caused new conditions to arise as a result of the lack of
pulsatility. Corwave’s pump design is using technology to support the heart
with the help of an undulating wave, similar to the movement of a fish in water,
propelling the blood forward. Corwave’s mission is to bring back pulsatility,
with increased reliability in a smaller pump in hopes to bring us back to our
natural physiology
Keywords— Cardiology, Heart Failure, Left Ventricular Assistive Device,
Transplant.
Biography
Michelle Johnson-Simmons has completed her Master’s of
Science Nursing and Acute Care Nurse Practitioner degree
at the age of 30 years old from University of California,
San Francisco. She is a Medical Research & Developer and
Clinical Research Associate at Corwave company, helping to
develop a new technological advanced LVAD (Left Ventricular
Assistive Device). She has worked as a Nurse Practitioner in
Electrophysiology and Trauma-Surgery. She has served more
than 15 years in public health working with the trauma-surgical,
psychiatric and underserved population. In total, she has
worked in the healthcare field for 20 years.
A new technologic advancement in Left Ventricular Assistive
Device for Heart Failure
Michelle C. Johnson-Simmons
Corwave, France
Michelle C. Johnson-Simmons, J Nurs Health Stud 2018, Volume: 3
DOI: 10.21767/2574-2825-C3-008